Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Indivior Pharmaceuticals Inc. (INDV) had Weighted-Average Shares Outstanding (Diluted) of 124.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$343.00M |
|
$122.00M |
|
$50.00M |
|
$293.00M |
|
$184.00M |
|
$159.00M |
|
$1.00M |
|
$160.00M |
|
$160.00M |
|
$122.00M |
|
$122.00M |
|
$122.00M |
|
$122.00M |
|
$159.00M |
|
$162.00M |
|
119.00M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
124.00M |
$1.02 |
|
$0.98 |
|
| Balance Sheet Financials | |
$725.00M |
|
$162.00M |
|
$507.00M |
|
$1.23B |
|
$868.00M |
|
$487.00M |
|
$573.00M |
|
$1.44B |
|
$-207.00M |
|
$-210.00M |
|
$-208.00M |
|
118.00M |
|
| Cash Flow Statement Financials | |
$220.00M |
|
$-27.00M |
|
$-166.00M |
|
$195.00M |
|
$222.00M |
|
$27.00M |
|
$20.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
1.75 |
|
-2.34 |
|
85.71% |
|
46.36% |
|
46.36% |
|
-- |
|
46.65% |
|
35.57% |
|
$193.00M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.33 |
|
1.20 |
|
75.31 |
|
-58.94% |
|
-58.10% |
|
9.89% |
|
43.73% |
|
$-1.76 |
|
$1.56 |
|
$1.77 |
|